Susquehanna International Group
IMUX icon

Susquehanna International Group’s Immunic IMUX Stock Holding History

Susquehanna International Group’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.6K Buy
5,460
+3,400
+165% +$30.5K ﹤0.01% 12577
2025
Q4 		$10.9K Sell
2,060
-1,620
-44% -$11.9K ﹤0.01% 12050
2025
Q3 		$32.4K Buy
+3,680
New +$32.5K ﹤0.01% 11966
2023
Q3 		– Sell
-1,900
Closed -$47.7K – 12446
2023
Q2 		$47.7K Buy
+1,900
New +$31.9K ﹤0.01% 11359
2023
Q1 		– Sell
-10,480
Closed -$147K – 13004
2022
Q4 		$147K Buy
10,480
+6,910
+194% +$188K ﹤0.01% 10525
2022
Q3 		$113K Buy
3,570
+1,320
+59% +$55.2K ﹤0.01% 11583
2022
Q2 		$78K Sell
2,250
-7,110
-76% -$456K ﹤0.01% 11689
2022
Q1 		$1.06M Buy
9,360
+6,720
+255% +$778K ﹤0.01% 6968
2021
Q4 		$253K Buy
2,640
+1,620
+159% +$146K ﹤0.01% 10904
2021
Q3 		$90K Hold
1,020
– – ﹤0.01% 12117
2021
Q2 		$125K Sell
1,020
-2,170
-68% -$300K ﹤0.01% 11969
2021
Q1 		$508K Sell
3,190
-6,870
-68% -$1.17M ﹤0.01% 9434
2020
Q4 		$1.54M Buy
10,060
+2,710
+37% +$487K ﹤0.01% 5690
2020
Q3 		$1.36M Buy
7,350
+1,770
+32% +$290K ﹤0.01% 5380
2020
Q2 		$676K Hold
5,580
– – ﹤0.01% 6725
2020
Q1 		$333K Sell
5,580
-5,420
-49% -$436K ﹤0.01% 7773
2019
Q4 		$1.07M Hold
11,000
– – ﹤0.01% 5401
2019
Q3 		$1.11M Sell
11,000
-70
-0.6% -$9.37K ﹤0.01% 5477
2019
Q2 		$1.27M Buy
11,070
+10,836
+4,631% +$1.42M ﹤0.01% 5136
2019
Q1 		$18K Sell
234
-2
-0.8% -$176 ﹤0.01% 8600
2018
Q4 		$18K Buy
236
+16
+7% +$1.87K ﹤0.01% 8691
2018
Q3 		$24K Buy
220
+42
+24% +$110K ﹤0.01% 8977
2018
Q2 		$488K Buy
178
+138
+345% +$319K ﹤0.01% 6836
2018
Q1 		$108K Buy
+40
New +$91.8K ﹤0.01% 8667
2017
Q1 		– Sell
-28
Closed -$48K – 9413
2016
Q4 		$48K Sell
28
-2
-7% -$4.38K ﹤0.01% 9297
2016
Q3 		$73K Sell
30
-34
-53% -$83.9K ﹤0.01% 8038
2016
Q2 		$159K Sell
64
-183
-74% -$601K ﹤0.01% 7782
2016
Q1 		$896K Sell
247
-34
-12% -$118K ﹤0.01% 5301
2015
Q4 		$1.3M Sell
281
-196
-41% -$640K ﹤0.01% 4896
2015
Q3 		$771K Buy
477
+366
+330% +$1.83M ﹤0.01% 6264
2015
Q2 		$933K Buy
+111
New +$1.06M ﹤0.01% 6363

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Susquehanna International Group's IMUX Position: Q1 2026 in Review

Susquehanna International Group increased its Immunic (IMUX) stake by 208% in Q1 2026, buying an estimated $622K and bringing the position to 102,826 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #7538.

Susquehanna International Group first reported a position in IMUX in Q2 2014 and has held it in 27 quarters since. The position peaked at $1.32M in Q1 2018. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Susquehanna International Group held 102,826 shares of Immunic worth $1.14M as of Q1 2026.
  • Susquehanna International Group bought 69,443 Immunic shares in Q1 2026, an estimated $622K.
  • Immunic made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7538 holding.
  • Susquehanna International Group first reported a position in Immunic in Q2 2014 and has held it in 27 quarters since.
  • Susquehanna International Group's Immunic position peaked at $1.32M in Q1 2018.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.